Timothy V. Waxweiler

Author

University of Colorado Denver ORCID

Also Known As

T Waxweiler, T. Waxweiler, T.V. Waxweiler, Timothy V Waxweiler, Timothy V. Waxweiler, Timothy Waxweiler

Publications

925

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver Emory University Beaumont Health St. Jude Children's Research Hospital

About

Timothy V. Waxweiler is an author at University of Colorado Denver specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	514
2	Health Sciences	3	3	123
3	Public Health	1	1	60
4	Health Policy	1	1	60
5	Neuroscience	1	1	12

Timothy V. Waxweiler

Publications

849

Citations

H-Index

Page 1

	Year	Citations
Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma Arya Amini, Timothy V. Waxweiler, Jeffrey V. Brower, JAMA Otolaryngology–Head & Neck Surgery	2016	127
The Impact of Definitive Local Therapy for Lymph Node-Positive Prostate Cancer: A Population-Based Study Chad G. Rusthoven, Julie A. Carlson, Timothy V. Waxweiler, International Journal of Radiation OncologyBiologyPhysics Definitive Local TherapyUrologyOncologyPopulation-based StudyGenitourinary Cancer	2014	111
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC Laurel B. Darragh, Michael W. Knitz, Junxiao Hu, Nature Cancer	2022	85
Exaggerated Eye Growth in IRBP-Deficient Mice in Early Development J. D. Wisard, Amanda E. Faulkner, Micah A. Chrenek, Investigative Ophthalmology & Visual Science	2011	61
In Vitro and In Vivo Enhancement of Chemoradiation Using the Oral PARP Inhibitor ABT-888 in Colorectal Cancer Cells Joseph W. Shelton, Timothy V. Waxweiler, Jerome C. Landry, International Journal of Radiation OncologyBiologyPhysics Tumor BiologyVivo EnhancementMedicinePharmacologyColorectal Cancer	2013	61
Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States Arya Amini, Chad G. Rusthoven, Timothy V. Waxweiler, Journal of the American Academy of Dermatology Adults Ages 18Health Care DisparityHealth PolicyHealth OutcomeMedicine	2015	60
The prognostic significance of Gleason scores in metastatic prostate cancer Chad G. Rusthoven, Julie A. Carlson, Timothy V. Waxweiler, Urologic Oncology Seminars and Original Investigations Prognostic EvaluationPrognostic BiomarkersUrologyGenitourinary CancerMedicine	2014	57
Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy Yevgeniy Vinogradskiy, Richard Castillo, Edward Castillo, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMulti-institutional Phase 2MedicineRespiratory TherapyRadiation Therapy Planning	2021	57
Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy Yevgeniy Vinogradskiy, Chad G. Rusthoven, Leah Schubert, International Journal of Radiation OncologyBiologyPhysics Interim AnalysisRadiation TherapyMedicineRespiratory TherapyClinical Radiation Oncology	2018	39
Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer Chad G. Rusthoven, Timothy V. Waxweiler, Peter E. DeWitt, Urologic Oncology Seminars and Original Investigations UrologySurgical OncologyRadiation TherapyGenitourinary CancerMedicine	2014	38

Page 1